RExPO22 - The 1st International Conference on Drug Repurposing

RExPO22 is the first installment in the RExPO conference series. The conference will take place in Maastricht, The Netherlands, from September 2nd to 3rd, 2022 and we are already looking forward to share the occasion with such a vibrant community of researchers and innovators.

Make sure to check the official conference landing page for the latest updates!

Our key topics

• Redefining disease
• Organ-agnostic medicine
• Network pharmacology
• Artificial Intelligence to serve drug repurposing
• The regulatory, ethical and safety perspectives
• Rethinking pharma - from lab to market
• 2D and 3D-printed drugs and drug reformulation
• The road to precision medicine
• Clinical trials: strategy and management

Meet our speakers

We have multiple collaborations around the world who pool together their knowledge and know how to deliver the best possible outcome in the single major opportunity in drug development, i.e drug repurposing.

Some of our already confirmed speakers include:

Practical information for attendees

• All presentations and discussions will be held in English.
• Photos, videos and audio recordings may be captured during the conference for promotional and dissemination-related purposes in print materials and on the Internet. You can retract your consent at any time by emailing the conference office at rexpo@repo4.eu
• Video and/or audio recording of conference sessions is only permitted with the consent of the author (in this case, the speaker). As a general rule, the photographing of any materials (e.g. slides) provided by the speaker is only permitted in consultation with the conference organizers -Maastricht University (UM)/ REPO4EU/ AUSTRALO- for individual reproductions and only in certain cases, such as for exclusive private use, even without permission. For requests of this nature, please contact the conference office at rexpo@repo4.eu
• A portrait of the speaker may only be distributed or displayed with his or her consent. Consequently, unauthorised photo/video/audio recordings of sessions can lead to various copyright infringements with corresponding negative consequences, such as claims for removal, injunction and/or claims for damages of the person infringing copyright.